A Prospective Registry of Spine Cancer Patients Undergoing Surgical decompression followed by Radiation Therapy for Spine Tumors

OBJECTIVE
To assess for local failure and progression free survival at 3,6, 9, 12, 15, 18, 21, and 24 months
To assess spine-specific quality-of-life at 3,6, 9, 12, 15, 18, 21, and 24 months
To assess overall survival at 12, 18, and 24 months
To assess dosimetry values including PTV coverage and dose to organs-at-risk (OARs)
To assess complications related to surgery and post-operative radiation treatment
Implant failures
It is hypothesized that with these data we will be able to describe the population of primary and metastatic spine tumor patients who undergo surgical decompression and instrumentation followed by radiation therapy and their respective outcomes.

For further information about clinical trials, please contact us at 732-235-7356.